https://farmakovijilansdernegi.org/ 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/ 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/etkinlik-4/14-eylul-2007-1 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/05-06-temmuz-2007-2 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/sunumlar-3 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/etkinlik-4/farmakovijilans-sempozyumu-4 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/makale-farmakovijilansin-ekonomi-politigi-nurettin-abacioglu-6 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/makale-guidelines-for-submitting-adverse-event-reports-for-publication-7 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/makale-current-drug-safety-ahmet-akici-8 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/metropol-cerkeslerinin-kararsiz-kitabi-light-versiyon-17 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijiart-6/shakespeare-ve-komedya-25 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/rasit-sidan-in-sectiklerinden-18 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijiart-6/genet-de-kurmaca-gercek-baglantisi-19 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/etkinlik-4/kongrenin-ardindan-36 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijiart-6/beckett-poetikasi-uzerinden-besik-degerlendirmesi-20 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/tfd-kfcg-e-bulteni-subat-sayisi-ndan-makale-21 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/etkinlik-4/i-ulusal-farmakovijilans-kongresi-23 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/duyurular-22 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/etkinlik-4/dun-bugun-yarin-farmakoepidemiyolojik-calismalar-24 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/resimler-31 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/isvec-amp-8217-te-ilac-yan-etkilerinden-olumler-34 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/etkinlik-4/ilaclarla-yapilan-gozlemsel-calismalar-kilavuzu-37 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijiart-6/farmakovijilansin-ekonomi-politigi-35 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/etkinlik-4/kongreden-resimler-32 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/etkinlik-4/farmakovijilansta-denetim-paneli-49 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/yeni-yil-mesaji-51 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/ilaclarla-yapilan-gozlemsel-calismalar-kilavuzu-52 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/farmakovijilans-denetim-kilavuzu-53 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/guncel-kitap-tanitimi-58 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/etkinlik-4/ilac-guvenliligi-59 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/-60 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/advers-etki-bildirimi-61 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/mutlu-yillar-62 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/etkinlik-4/farmakovijilans-egitim-ve-sertifikasyon-toplantisi-65 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/ilaclarin-guvenli-kullanimi-66 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/etkinlik-4/demet-aydin-karahaliloglu-nun-katildigi-program-94 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijivizyon-5/test-71 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/etkinlik-4/11th-isop-annual-meeting-72 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/etkinlik-4/11-isop-konferansi-duyurusu-73 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/mutlu-yillar-76 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/etkinlik-4/farmakovijilans-toplantisi-77 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/tufam-tarafindan-surekli-izlenen-linkler-79 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/ilac-yan-etkisi-bildirimi-hakkinda-onemli-duyuru-86 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/2013-pv-ajandasi-87 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/etkinlik-4/isop-turkiye-toplantisi-96 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/etkinlik-4/ilac-guvenligi-98 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/tanimlar-108 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/etkinlik-4/vijilansa-stratejik-bakis-tehtidler-ve-firsatlar-99 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/ema-aktif-madde-bazinda-farkli-marka-ve-farkli-formdaki-tum-pggr-leri-ayni-anda-inceleyecek-100 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/prac-recommends-withdrawal-of-benzodiazepine-in-europe-106 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/bitkisel-urunler-de-ilac-etkilesimleri-ve-yaratabilecegi-toksisite-111 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/mhra-press-statement-on-ranbaxy-mhra-113 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/tufam-meddra-sistemine-gecti-114 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/omega-3-hapi-kanser-yapiyor-118 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/pharmacovigilance-development-of-a-drug-safety-eplatform-for-physicians-pharmacists-and-consumers-120 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/severe-skin-reactions-investigated-with-valsartan-in-japan-123 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/akilci-ilac-kullaniminda-onemli-yeni-gelisme-125 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/talidomid-de-tazminat-127 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/azithromycin-and-levofloxacin-use-and-increased-risk-of-cardiac-arrhythmia-and-death-166 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/ilaclarin-guvenliligi-hakkinda-yonetmelik-164 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/sandoz-receives-biosimilar-filgrastim-approval-in-japan-165 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/macrolide-antibiotics-associated-with-infantile-hypertrophic-pyloric-stenosis-163 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/ssri-may-negatively-affect-male-fertility-160 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/doctors-often-comply-when-patients-ask-for-advertised-drugs-study-161 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/monthly-summary-of-drug-label-changes-december-2013-159 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/ema-publishes-its-work-programme-for-2014-158 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/off-label-use-amp-safety-167 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/digital-drug-safety-surveillance-monitoring-pharmaceutical-products-in-twitter-168 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/ema-to-allow-biosimilar-applications-to-reference-data-from-products-approved-outside-eu-170 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/fda-launches-big-data-openfda-initiative-giving-public-easier-access-to-safety-information-171 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/saglik-doga-ve-sanat-bulusuyor-172 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/naproxen-cv-safety-vs-ibuprofen-challenged-in-whi-analysis-174 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/titck-ek-izlemeye-tabi-ilaclar-listesi-yayimladi-175 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/list-of-medicines-under-additional-monitoring-176 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/regulatory-information-european-medicines-agency-s-guidance-on-european-union-periodic-safety-report-single-assessment-for-nationally-authorised-medicines-178 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/patient-safety-in-the-eu-179 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/stimulated-reporting-the-impact-of-us-food-and-drug-administration-issued-alerts-on-the-adverse-event-reporting-system-faers-180 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/pregnancy-lactation-and-reproductive-potential-labeling-for-human-prescription-drug-and-biological-products-content-and-format-draft-guidance-for-industry-availability-181 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/increased-bioavailability-of-phenylephrine-by-co-administration-of-acetaminophen-184 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/the-placebome-where-genetics-and-the-placebo-effect-meet-185 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/vefat-haberi-186 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/farmateam-farmakovijilans-egitim-seminerleri-serisi-187 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/multiple-er-visits-linked-to-risk-of-prescription-drug-overdose-death-188 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/ii-ulusal-farmakovijilans-kongresi-189 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/chronic-use-of-proton-pump-inhibitors-increases-heart-risk-191 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/ramazan-bayrami-tebrigi-192 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/paxil-isn-t-safe-for-teens-new-analysis-says-194 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/kurban-bayrami-tebrigi-195 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/iyi-klinik-uygulamalar-kilavuzu-196 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/etkinlik-4/ii-farmakovijilans-kongresi-198 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/farmakovijilansta-denetim-toplantisi-199 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/etkinlik-4/vijilans-ta-denetim-toplantisi-200 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/reporting-of-adverse-events-in-published-and-unpublished-studies-of-health-care-interventions-a-systematic-review-201 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/isop-mid-year-training-course-in-bangkok-25-amp-amp-26-may-2017-202 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/ten-drugs-make-new-fda-watch-list-204 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/drugs-that-cause-kidney-damage-205 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/farmakovijilansta-veri-gizliligi-206 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/farmakovijilansta-veri-gizliligi-207 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/etkinlik-4/3-ulusal-farmakovijilans-kongresi-basariyla-gerceklesmistir-2018-yili-egitim-etkinliklerimiz-icin-lutfen-bizi-takip-ediniz-209 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/farmakovijilansta-veri-gizliligi-sunumlar-208 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/etkinlik-4/iii-ulusal-farmakovijilans-kongresi-210 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/farmakoloji-asistani-ve-uzmanlarina-yonelik-farmakovijilans-sempozyumu-231 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/medwatch-the-fda-safety-information-and-adverse-event-reporting-program-216 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/turkiye-ile-ilgili-turk-yazarlarca-yazilmis-farmakovijilans-yayinlari-236 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/farmakoloji-asistani-ve-uzmanlarina-yonelik-farmakovijilans-sempozyumu-232 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijivizyon-5/siteye-6-aydan-once-eklenenler-239 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/ema-farmakovijilans-ve-risk-degerlendirme-komitesi-duyurusu-226 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/top-ten-drugs-tied-to-overdose-deaths-227 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/association-of-adverse-effects-of-medical-treatment-with-mortality-in-the-united-statesa-secondary-analysis-of-the-global-burden-of-diseases-injuries-and-risk-factors-study-229 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/diger-farmakovijilans-yayinlari-233 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/turkiye-ile-ilgili-turk-yazarlarca-yazilmis-farmakovijilans-yayinlari-234 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/diger-farmakovijilans-yayinlari-237 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijivizyon-5/siteye-son-6-ay-icinde-eklenenler-238 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijivizyon-5/siteye-son-6-ay-icinde-eklenenler-240 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijivizyon-5/siteye-6-aydan-once-eklenenler-241 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/onemli-duyuru-245 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/duyuru-246 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/duyuru-247 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/30-agustos-zafer-bayraminiz-kutlu-olsun-248 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/dunya-hasta-guvenligi-gununuz-kutlu-olsun-249 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/29-ekim-cumhuriyet-bayraminiz-kutlu-olsun-250 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/yeni-yiliniz-kutlu-olsun-251 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/farmakovijilans-dernegi-olagan-genel-kurul-toplantisina-davet-mektubu-252 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/prof-dr-semra-sardas-gorev-yapmakta-oldugu-istinye-universitesi-eczacilik-fakultesi-dekanligina-atanmistir-253 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/kurban-bayraminiz-kutlu-olsun-254 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/atamizi-saygi-ve-ozlemle-aniyoruz-255 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2/vefat-ve-bassagligi-256 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/farmakovijilans-dernegi-olagan-genel-kurul-toplantisi-davet-mektubu-257 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1/meddra-coding-ve-safety-data-analysis-egitimi-hk-258 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/klinik-arastirmalar-dernegi-baskanligina-dr-ecz-hilal-ilbars-secildi-259 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/etkinlik-4/sinyallerin-otesi-toplantisi-260 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3/sinyallerin-otesi-toplantisi-erken-kayit-tarihi-261 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/hakkimizda 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/linkler 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/mevzuat 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/dernekanatuzugu 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/tarihce 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/tarihce 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/tarihce 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/dernak-tarihcesi 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/yonetimkurulu 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/denetlemekurulu 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/onursal-baskanin-anisina 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/bize-ulasin 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/uyelik 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/advers-reaksiyon-bildirimi 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/tanimlar 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/mevzuat 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijilans-dunyasindan-yansimalar-1 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/turk-basinindan-yansimalar-2 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/haberler-3 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/etkinlik-4 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijivizyon-5 2026-04-04 weekly 0.8 https://farmakovijilansdernegi.org/icerik/vijiart-6 2026-04-04 weekly 0.8